Patents by Inventor Suresh Shenoy

Suresh Shenoy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SENSOR MEASUREMENT CORRECTION BASED ON EMPIRICAL DATA
    Publication number: 20240094269
    Abstract: In an aspect, measurement processing circuitry may obtain, from a sensor, a first measured value of a measured object, the first measured value corresponding to a first power consumption level of the measured object at a first time point. The measurement processing circuitry may obtain, from the sensor, one or more second measured values of the measured object, the one or more second measured values corresponding to one or more second power consumption levels of the measured object at one or more second time points earlier than the first time point. The measurement processing circuitry may determine a corrected value based on the first measured value and the one or more second measured values, the corrected value representing the first power consumption level of the measured object at the first time point.
    Type: Application
    Filed: September 20, 2022
    Publication date: March 21, 2024
    Inventors: Krishna Sai Anirudh KATAMREDDY, Suresh SHENOY, Kevin Bradley CITTERELLE
  • Smokeless compressed tobacco product for oral consumption
    Patent number: 8714163
    Abstract: A consumable compressed tobacco product adapted to dissolve in an oral cavity. The compressed tobacco product is formed from a composition that includes at least one tobacco component, at least one flavorant, at least one filler-binder, at least one lubricant, at least one desiccant and at least one glidant. The compressed tobacco products are adapted to dissolve and provide tobacco satisfaction. A method of making a dissolvable compressed tobacco product is also provided.
    Type: Grant
    Filed: August 8, 2012
    Date of Patent: May 6, 2014
    Assignee: Philip Morris USA Inc.
    Inventors: Ashok Kumar, Suresh Shenoy, Carolina Marun, William R. Sweeney, Manuel Marquez-Sanchez, Jon Regrut, Gregory J. Griscik, David R. Golob
  • Smokeless compressed tobacco product for oral consumption
    Patent number: 8336557
    Abstract: A consumable compressed tobacco product adapted to dissolve in an oral cavity. The compressed tobacco product is formed from a composition that includes at least one tobacco component, at least one flavorant, at least one filler-binder, at least one lubricant, at least one desiccant and at least one glidant. The compressed tobacco products are adapted to dissolve and provide tobacco satisfaction. A method of making a dissolvable compressed tobacco product is also provided.
    Type: Grant
    Filed: November 26, 2008
    Date of Patent: December 25, 2012
    Assignee: Philip Morris USA Inc.
    Inventors: Ashok Kumar, Carolina Marun, Gregory J. Griscik, David R. Golob, Jon Regrut, Suresh Shenoy, William R. Sweeney, Manuel Marquez-Sanchez
  • SMOKELESS COMPRESSED TOBACCO PRODUCT FOR ORAL CONSUMPTION
    Publication number: 20120298121
    Abstract: A consumable compressed tobacco product adapted to dissolve in an oral cavity. The compressed tobacco product is formed from a composition that includes at least one tobacco component, at least one flavorant, at least one filler-binder, at least one lubricant, at least one desiccant and at least one glidant. The compressed tobacco products are adapted to dissolve and provide tobacco satisfaction. A method of making a dissolvable compressed tobacco product is also provided.
    Type: Application
    Filed: August 8, 2012
    Publication date: November 29, 2012
    Applicant: ALTRIA CLIENT SERVICES INC.
    Inventors: Ashok KUMAR, Carolina MARUN, Gregory J. GRISCIK, David R. GOLOB, Jon REGRUT, Suresh SHENOY, William R. SWEENEY, Manuel Marquez-Sanchez
  • SMOKELESS COMPRESSED TOBACCO PRODUCT FOR ORAL CONSUMPTION
    Publication number: 20090293889
    Abstract: A consumable compressed tobacco product adapted to dissolve in an oral cavity. The compressed tobacco product is formed from a composition that includes at least one tobacco component, at least one flavorant, at least one filler-binder, at least one lubricant, at least one desiccant and at least one glidant. The compressed tobacco products are adapted to dissolve and provide tobacco satisfaction. A method of making a dissolvable compressed tobacco product is also provided.
    Type: Application
    Filed: November 26, 2008
    Publication date: December 3, 2009
    Applicant: PHILIP MORRIS USA INC.
    Inventors: Ashok Kumar, Carolina Marun, Gregory J. Griscik, David R. Golob, Jon Regrut, Suresh Shenoy, William R. Sweeney, Manuel Marquez-Sanchez
  • Fluoropolymer-carbon dioxide compositions and methods of processing fluoropolymers
    Patent number: 7115685
    Abstract: Fluoropolymer materials containing tetrafluoroethylene monomers, such as PTFE, are significantly swollen by supercritical carbon dioxide at high temperatures and pressures. The swollen fluoropolymer is processable by molding, extrusion, and other techniques. In addition, the fluoropolymer may be sintered at significantly lower temperatures compared to a nonswollen fluoropolymer material. The melting temperature of fluorinated polymers containing tetrafluoroethylene and triflouroethylene monomers which are swollen with supercritical carbon dioxide is significantly reduced, thereby permitting manufacturing operations such as extruding and molding to be performed at lower temperatures and with reduced risk of decomposition.
    Type: Grant
    Filed: March 22, 2005
    Date of Patent: October 3, 2006
    Assignees: Daikin Institute of Advanced Chemistry and Technology (DAI-ACT), Virginia Commonwealth University
    Inventors: Kenneth Wynne, Takako Ohsaka, legal representative, Suresh Shenoy, Sadashige Irie, Younosuke Ohsaka, deceased
  • Novel proteins and nucleic acids encoding same
    Publication number: 20060211031
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: April 6, 2006
    Publication date: September 21, 2006
    Inventors: Haihong Zhong, William LaRochelle, Suresh Shenoy, Nikolai Khramtsov
  • Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
    Publication number: 20060210559
    Abstract: Disclosed herein are nucleic acid sequences that encode polypeptides. Also disclosed are antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids, polypeptides, or antibodies, or fragments thereof.
    Type: Application
    Filed: March 20, 2006
    Publication date: September 21, 2006
    Inventors: William LaRochelle, Suresh Shenoy, Mohan Dhanabal, Nikolai Khramtsov, Craig Hackett
  • Novel proteins and nucleic acids encoding same
    Publication number: 20060084054
    Abstract: The present invention provides novel isolated polynucleotides and small molecule target polypeptides encoded by the polynucleotides. Antibodies that immunospecifically bind to a novel small molecule target polypeptide or any derivative, variant, mutant or fragment of that polypeptide, polynucleotide or antibody are disclosed, as are methods in which the small molecule target polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states. More specifically, the present invention discloses methods of using recombinantly expressed and/or endogenously expressed proteins in various screening procedures for the purpose of identifying therapeutic antibodies and therapeutic small molecules associated with diseases. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 4, 2003
    Publication date: April 20, 2006
    Inventors: John Alsobrook, David Anderson, Jason Baumgartner, Constance Berghs, Ferenc Boldog, Catherine Burgess, Stacie Casman, Elina Catterton, Mohanraj Dhanabal, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, William Grosse, Erik Gunther, Xiaojia Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Nikolai Khramtsov, William LaRochelle, Li Li, Hongping Liang, Kenneth Low, John MacDougall, Timothy Maclachlan, Uriel Malyankar, Kelly McQueeney, Amanda Mezick, Charles Miller, Isabelle Millet, Muralidhara Padigaru, Meera Patturajan, John Peyman, Xiaozhong Qian, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Sujatha Sukumaran, Edward Szekeres, Corine Vernet, Edward Voss, Adam Wolenc, Mei Zhong, Haihong Zhong
  • Proteins and nucleic acids encoding same
    Publication number: 20060009634
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: December 21, 2004
    Publication date: January 12, 2006
    Inventors: Ramesh Kekuda, John Alsobrook, Velizar Tchernev, Xiaohong Liu, Kimberly Spytek, Meera Patturajan, William Grosse, Denise Lepley, Catherine Burgess, Corine Vernet, Li Li, Linda Gorman, Shlomit Edinger, Paul Sciore, Karen Ellerman, Uriel Malyankar, Mark Rothenberg, David Stone, Ferenc Boldog, Xiaojia Guo, Suresh Shenoy, David Anderson, Muralidhara Padigaru, Raymond Taupier, Charles Miller, Andrew Eisen
  • Therapeutic polypeptides, nucleic acids encoding same, and methods of use
    Publication number: 20060003323
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 3, 2003
    Publication date: January 5, 2006
    Inventors: John Alsobrook, Enrique Alvarez, David Anderson, Ferenc Boldog, Stacie Casman, Elina Catterton, Andrei Chapoval, Julie Crabtree-Bokor, Shlomit Edinger, Karen Ellerman, Seth Ettenberg, Esha Gangolli, Valerie Gerlach, Linda Gorman, Erik Gunther, Xiaojia (Sasha) Guo, Vladimir Gusev, John Herrmann, Weizhen Ji, Ramesh Kekuda, Li Li, Xiaohong Liu, John MacDougall, Timothy Machlachlan, Uriel Malyankar, Amanda Mezick, Isabelle Millet, Vishnu Mishra, Muralidhara Padigaru, Meera Patturajan, Carol Pena, John Peyman, Debasish Raha, Luca Rastelli, Daniel Rieger, Mark Rothenberg, Paul Sciore, Suresh Shenoy, Richard Shimkets, Glennda Smithson, Kimberly Spytek, David Stone, Corine Vernet, Edward Voss, Mei Zhong, Hiahong Zhong
  • Fluoropolymer-carbon dioxide compositions and methods of processing fluoropolymers
    Patent number: 6960633
    Abstract: Fluoropolymer materials containing tetrafluoroethylene monomers, such as PTFE, are significantly swollen by supercritical carbon dioxide at high temperatures and pressures. The swollen fluoropolymer is processable by molding, extrusion, and other techniques. In addition, the fluoropolymer may be sintered at significantly lower temperatures compared to a nonswollen fluoropolymer material. The melting temperature of fluorinated polymers containing tetrafluoroethylene and triflouroethylene monomers which are swollen with supercritical carbon dioxide is significantly reduced, thereby permitting manufacturing operations such as extruding and molding to be performed at lower temperatures and with reduced risk of decomposition.
    Type: Grant
    Filed: October 11, 2002
    Date of Patent: November 1, 2005
    Assignees: Virginia Commonwealth University, Daikin Institute of Advanced Chemistry and Technology (Dai-Act)
    Inventors: Kenneth Wynne, Suresh Shenoy, Sadashige Irie, Takako Ohsaka, Younosuke Ohsaka
  • Fluoropolymer-carbon dioxide compositions and methods of processing fluoropolymers
    Publication number: 20050239951
    Abstract: Fluoropolymer materials containing tetrafluoroethylene monomers, such as PTFE, are significantly swollen by supercritical carbon dioxide at high temperatures and pressures. The swollen fluoropolymer is processable by molding, extrusion, and other techniques. In addition, the fluoropolymer may be sintered at significantly lower temperatures compared to a nonswollen fluoropolymer material. The melting temperature of fluorinated polymers containing tetrafluoroethylene and triflouroethylene monomers which are swollen with supercritical carbon dioxide is significantly reduced, thereby permitting manufacturing operations such as extruding and molding to be performed at lower temperatures and with reduced risk of decomposition.
    Type: Application
    Filed: June 27, 2005
    Publication date: October 27, 2005
    Inventors: Kenneth Wynne, Younosuke Ohsaka, Takako Ohsaka, Suresh Shenoy, Sadashige Irie
  • Fluoropolymer-carbon dioxide compositions and methods of processing fluoropolymers
    Publication number: 20050179170
    Abstract: Fluoropolymer materials containing tetrafluoroethylene monomers, such as PTFE, are significantly swollen by supercritical carbon dioxide at high temperatures and pressures. The swollen fluoropolymer is processable by molding, extrusion, and other techniques. In addition, the fluoropolymer may be sintered at significantly lower temperatures compared to a nonswollen fluoropolymer material. The melting temperature of fluorinated polymers containing tetrafluoroethylene and triflouroethylene monomers which are swollen with supercritical carbon dioxide is significantly reduced, thereby permitting manufacturing operations such as extruding and molding to be performed at lower temperatures and with reduced risk of decomposition.
    Type: Application
    Filed: March 22, 2005
    Publication date: August 18, 2005
    Inventors: Kenneth Wynne, Younosuke Ohsaka, Suresh Shenoy, Sadashige Irie, Takako Ohsaka
  • Novel human proteins and polynucleotides encoding them
    Publication number: 20050170380
    Abstract: The present invention provides novel isolated SECX polynucleotides and the membrane-associated or secreted polypeptides encoded by the SECX polynucleotides. Also provided are the antibodies that immunospecifically bind to a SECX polypeptide or any derivative, variant, mutant or fragment of the SECX polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the SECX polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: October 21, 2004
    Publication date: August 4, 2005
    Applicant: CuraGen Corporation
    Inventors: Elma Fernandes, Corine Vernet, Richard Shimkets, David Anderson, Muralidhara Padigaru, Ferenc Boldog, Li Li, Suresh Shenoy, Stacie Casman, Luca Rastelli
  • Therapeutic polypeptides, nucleic acids encoding same, and methods of use
    Publication number: 20050053930
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: June 3, 2003
    Publication date: March 10, 2005
    Inventors: David Anderson, Ferenc Boldog, Catherine Burgess, Stacie Casman, Shlomit Edinger, Andrew Eisen, Karen Ellerman, Valerie Gerlach, Linda Gorman, Xiaojia Guo, Vladimir Gusev, Weizhen Ji, Li Li, John MacDougall, Uriel Malyankar, Isabelle Millet, Tatiana Ort, Muralidhara Padigaru, Sudhirdas Prayaga, Meera Patturajan, Carol Pena, John Peyman, Daniel Rieger, Mark Rothenberg, Paul Sciore, Suresh Shenoy, Glennda Smithson, Kimberly Spytek, David Stone, Raymond Taupier, Velizar Tchernev, Corine Vernet, Edward Voss, Bryan Zerhusen, Mei Zhong
  • Therapeutic polypeptides, nucleic acids encoding same, and methods of use
    Publication number: 20040162236
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide. Vectors, host cells, antibodies and recombinant methods for producing the polypeptides and polynucleotides, as well as methods for using same are also included. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: March 31, 2003
    Publication date: August 19, 2004
    Inventors: John Alsobrook, Patricia Bento, Ferenc Boldog, Catherine Burgess, Stacie Casman, Julie Crabtree Bokor, Shlomit R. Edinger, Karen Ellerman, Elma Fernandes, Valerie Gerlach, William Grosse, Erik Gunther, Vladimir Gusev, Melvyn Heyes, Denise Lepley, Li Li, John R. MacDougall, Uriel M. Malyankar, Isabelle Millet, Meera Patturajan, John A. Peyman, Luca Rastelli, Daniel Rieger, Suresh Shenoy, Richard Shimkets, Glennda Smithson, David Stone, Corine Vernet, Edward Voss
  • Novel human proteins, polynucleotides encoding them and methods of using the same
    Publication number: 20040024181
    Abstract: Disclosed herein are nucleic acid sequences that encode novel polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: October 26, 2001
    Publication date: February 5, 2004
    Inventors: Esha A. Gangolli, Kimberly A. Spytek, Jennifer Gilbert, Stacie Casman, Angela Blalock, Li Li, Corine Vernet, Suresh Shenoy, Vishnu S. Mishra, Katarzyna Furtak, Valerie L. Gerlach, Shlomit Edinger, Uriel Malyanker, David Stone, Isabelle Millet, Glennda Smithson, Erik Gunther, Karen Ellerman, Muralidhara Padigaru, Raymond J. Taupier, David W. Anderson
  • Fluoropolymer-carbon dioxide compositions and methods of processing fluoropolymers
    Publication number: 20030230834
    Abstract: Fluoropolymer materials containing tetrafluoroethylene monomers, such as PTFE, are significantly swollen by supercritical carbon dioxide at high temperatures and pressures. The swollen fluoropolymer is processable by molding, extrusion, and other techniques. In addition, the fluoropolymer may be sintered at significantly lower temperatures compared to a nonswollen fluoropolymer material. The melting temperature of fluorinated polymers containing tetrafluoroethylene and triflouroethylene monomers which are swollen with supercritical carbon dioxide is significantly reduced, thereby permitting manufacturing operations such as extruding and molding to be performed at lower temperatures and with reduced risk of decomposition.
    Type: Application
    Filed: October 11, 2002
    Publication date: December 18, 2003
    Inventors: Kenneth Wynne, Takako Ohsaka, Suresh Shenoy, Sadashige Irie, Youosuke Ohsaka
  • Novel proteins and nucleic acids encoding same
    Publication number: 20030195335
    Abstract: Disclosed herein are nucleic acid sequences that encode G-coupled protein-receptor related polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies, which immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.
    Type: Application
    Filed: January 11, 2002
    Publication date: October 16, 2003
    Inventors: William M. Grosse, Edward S. Szekeres, Stacie Casman, John P. Alsobrook, Catherine E. Burgess, Muralidhara Padigaru, Sarah Taylor, Velizar T. Tchernev, Kimberly A. Spytek, Li Li, Suresh Shenoy, Ramesh Kekuda, Esha A. Gangolli, David J. Stone, Glennda Smithson, John R. MacDougall